GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,512 Cr | ₹2,572 Cr | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹2,512 Cr |
| Mar2025 | ₹2,572 Cr |
| Mar2024 | ₹2,545 Cr |
| Mar2023 | ₹2,447 Cr |
| Mar2022 | ₹2,516 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,512 Cr | -2.31 | |
| Mar2025 | ₹2,572 Cr | 1.05 | |
| Mar2024 | ₹2,545 Cr | 3.99 | |
| Mar2023 | ₹2,447 Cr | -2.73 | |
| Mar2022 | ₹2,516 Cr | - | |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹44,949.4 Cr | 3.8% | 5.9% | -16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.8% |
5.9% |
-16.1% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses